Entereg (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the Entereg drug offered from Merck Sharp & Dohme Corp.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | alvimopan |
| SUBSTANCE NAME: | ALVIMOPAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-04-16 |
| END MARKETING DATE: | 0000-00-00 |
Entereg HUMAN PRESCRIPTION DRUG Details:
| Item Description | Entereg from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12(mg/1) |
| START MARKETING DATE: | 2012-04-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67919-020_71ec574e-4b7b-4f58-8577-da61fd5506d7 |
| PRODUCT NDC: | 67919-020 |
| APPLICATION NUMBER: | NDA021775 |
Other ALVIMOPAN Pharmaceutical Manufacturers / Labelers:
